Prevalence of Patient-Reported Gastrointestinal Symptoms and Concordance With Clinician Toxicity Assessments in Radiation Therapy for Anal Cancer

Purpose Gastrointestinal (GI) symptoms pose a significant burden to patients receiving chemoradiation therapy (CRT) for anal cancer; however, the impact of symptoms from the patient perspective has not been quantified. This retrospective study examined and compared patient and clinician reports of acute GI toxicity during CRT.